Literature DB >> 27069176

Magnetic Resonance Imaging for the Pre-Surgical Assessment of Endometrial Cancer: Results in a Routine Clinical Setting, Outside Dedicated Trials; a Cross-sectional Study.

Javier Arnaiz1, Ana-Belen Muñoz2, Virginia Verna2, Irene Gonzalez-Rodilla3, Jose Schneider4.   

Abstract

AIM: To assess the efficacy of magnetic resonance imaging (MRI) in predicting the surgical stage of endometrial carcinoma as a diagnostic tool, in a routine clinical setting, and not just in dedicated pilot studies or trials.
MATERIALS AND METHODS: The stage prediction made on MRI, as stated in the Radiology report, was compared with the effective surgical stage registered in the Pathology report. The 2009 International Federation of Gynecology and Obstetrics (FIGO) staging was used.
RESULTS: MRI and surgical stage correlated significantly (p<0.0001, r=0.43). However, there was only full concordance between predicted and true stage in 47.2% (43/91) of cases. Conversely, 11% (10/91) of cases were overstaged by MRI, whereas 41.8% (38/91) were understaged. For type-I tumors, where the decision to perform lymphadenectomy or not is crucial, there was full concordance in 63.9% of cases. What is more important, neither understaging (eight cases), nor overstaging (five cases) by MRI would have resulted in modification of the global treatment schedule, and thus potentially of prognosis. However, five patients would have undergone unnecessary surgery. On the other hand, half of the patients would have been correctly spared extended surgery.
CONCLUSION: If restricted to type-I tumors, pre-surgical MRI appears useful under routine clinical conditions, and helps avoid unnecessary surgery in 50% of selected cases. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Endometrium; carcinoma; magnetic resonance; staging

Mesh:

Year:  2016        PMID: 27069176

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

2.  RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients.

Authors:  Marika Vezzoli; Antonella Ravaggi; Laura Zanotti; Rebecca Angelica Miscioscia; Eliana Bignotti; Monica Ragnoli; Angela Gambino; Giuseppina Ruggeri; Stefano Calza; Enrico Sartori; Franco Odicino
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

3.  Inguinal lymph node presenting as the delayed site of metastasis in early stage endometrial carcinoma: Case report.

Authors:  Shomaila Amir M Akbar; Mutahir A Tunio; Wafa AlShakweer; AbdulAziz AlObaid; Mushabbab AlAsiri
Journal:  Int J Surg Case Rep       Date:  2017-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.